Infectious Disease
Tebas P, Jadlowsky JK, Shaw PA, Tian L, Esparza E, Brennan A, Kim S, Naing SY, Richardson MW, Vogel AN, Maldini C, Kong H, Liu X, Lacey SF, Bauer AB, Mampe F, Richman LP, Lee G, Ando D, Levine BL, Porter DL, Zhao Y, Siegel DL, Bar KJ, June CH, and Riley JL. CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication. To appear in The Journal of Clinical Investigation.
Tebas P, Jadlowsky JK, Shaw PA, Tian L, Esparza E, Brennan A, Kim S, Naing SY, Richardson MW, Vogel AN, Maldini C, Kong H, Liu X, Lacey SF, Bauer AB, Mampe F, Richman LP, Lee G, Ando D, Levine BL, Porter DL, Zhao Y, Siegel DL, Bar KJ, June CH, and Riley JL. CCR5-edited CD4 […]
Wasserman D. Alameh MG, de Silva T, Collini P, Hornsby H, Brown R, LaBranche CC, Edwards RJ, Sutherland L, Santra S, Mansouri K, Gobeil S, McDanal C, Pardi N, Hengartner N, Lin PJC, Tam Y, Shaw PA Lewis MG, Boesler C, Şahin U, Acharya P, Haynes BF, Korber B, Montefiori DC. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. Cell Host & Microbe; 2021 Jan 13; v29: 23–31.
Wasserman D. Alameh MG, de Silva T, Collini P, Hornsby H, Brown R, LaBranche CC, Edwards RJ, Sutherland L, Santra S, Mansouri K, Gobeil S, McDanal C, Pardi N, Hengartner N, Lin PJC, Tam Y, Shaw PA Lewis MG, Boesler C, Şahin U, Acharya P, Haynes BF, Korber B, Montefiori DC. D614G Spike Mutation Increases […]
Bien-Gund CH, Choi GH, Mashas A, Shaw PA, Miller M, Gross R, and Brady KA. Persistent disparities in smoking rates among PLWH compared to the general population in Philadelphia, 2009-2014 AIDS and Behavior, 2020 Jun 26; v25: 148-153.
Bien-Gund CH, Choi GH, Mashas A, Shaw PA, Miller M, Gross R, and Brady KA. Persistent disparities in smoking rates among PLWH compared to the general population in Philadelphia, 2009-2014 AIDS and Behavior, 2020 Jun 26; v25: 148-153. [PDF]
Steytler J, Shaw PA, Pau AK, Khabo P, Joshi G, Oelofse P, and Phidisa 2 Study Team. Analysis of Site Heterogeneity and HIV Outcomes Across Rural and Urban Study Sites in Phidisa II – A Multi-site Randomized Controlled Antiretroviral Treatment Trial in a South African Military Cohort. Current HIV Research 2017 May;15(3):178-187.
Steytler J, Shaw PA, Pau AK, Khabo P, Joshi G, Oelofse P, and Phidisa 2 Study Team. Analysis of Site Heterogeneity and HIV Outcomes Across Rural and Urban Study Sites in Phidisa II – A Multi-site Randomized Controlled Antiretroviral Treatment Trial in a South African Military Cohort. Current HIV Research 2017 May;15(3):178-187.
Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D’souza J, Halegoua-De Marzio D, Goldberg DS, Trooskin S, Levine LD, Srinivas SK, Lewis JD, Forde KA, Lo Re V 3rd: Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study. Liver International 38(5): 813-20, May 2018.
Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D’souza J, Halegoua-De Marzio D, Goldberg DS, Trooskin S, Levine LD, Srinivas SK, Lewis JD, Forde KA, Lo Re V 3rd: Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study. Liver International […]
Gowda C, Coppock D, Brickman C, Shaw PA, Gross R.: Determinants of HIV Transmission Risk Among HIV-Infected Persons Engaged in Care. AIDS Education and Prevention, 2016 Oct; 28(5):440-452.
Gowda C, Coppock D, Brickman C, Shaw PA, Gross R.: Determinants of HIV Transmission Risk Among HIV-Infected Persons Engaged in Care. AIDS Education and Prevention, 2016 Oct; 28(5):440-452.
Gowda C, Brown T, Compher C, Forde K, Kostman J, Shaw PA, Tien P, Lo Re V: Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS, 2016 Oct 23; 30(16):2519-2528.
Gowda C, Brown T, Compher C, Forde K, Kostman J, Shaw PA, Tien P, Lo Re V: Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS, 2016 Oct 23; 30(16):2519-2528.
Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM Prevots DR.: Mortality among Patients with Pulmonary Nontuberculous Mycobacterial Disease. International Journal of TB and Lung Disease, 2016 May; 20(5): 582-587.
Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM Prevots DR.: Mortality among Patients with Pulmonary Nontuberculous Mycobacterial Disease. International Journal of TB and Lung Disease, 2016 May; 20(5): 582-587.
Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT, Taubenberger JK. : Evaluation of Anti-Hemagglutinin and Anti-Neuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model. mBio April 2016; 7(2) doi: 10.1128/mBio.00417-16.
Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT, Taubenberger JK. : Evaluation of Anti-Hemagglutinin and Anti-Neuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model. mBio April 2016; 7(2) doi: 10.1128/mBio.00417-16. [PDF]
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702.
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702. [PDF]